Abstract
A comparative proteomic study of secretomes of virulent and avirulent Bacillus anthracis strains in various culturing conditions, including those encountered in the host (high CO2/bicarbonate), enabled identification of approximately 70 proteins representing collectively more than 99% of the secretome. In-vivo expression of 50 proteins was established by 2-dimension Western-analysis using anti B. anthracis immune sera. Many of the abundant proteins harbor features characteristic of virulence determinants and exhibit different patterns of expression. In minimal medium, virulent and avirulent B. anthracis strains manifest similar protein signatures and the metalloprotease NprA, (previously suggested to act in the context of a starvation-induced mechanism), represents 90% of the total secretome. Under high CO2/bicarbonate, NprA is repressed (possibly by a mechanism which preserves toxin integrity), while other proteins, including the bacterial toxins, are induced. One of the immunogens observed to be induced under high CO2-tension, was HtrA. We investigated the phenotype associated with disruption of HtrA by biochemical and proteomic approaches. The HtrA- bacteria are severely affected in their ability to respond to stress and fail to secrete the most abundant extracellular protease NprA. Most surprisingly, HtrA- cells do not possess the characteristic S-layer. This unique phenotype may have important implications for the role of HtrA in manifestation of B. anthracis virulence. Furthermore, the data show that distinct CO2/bicarbonate responsive chromosome-and plasmid-encoded regulatory factors modulate the secretion of potential novel virulence factors, most of which are associated with extracellular proteolytic activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ariel, N., Zvi, A., Grosfeld, H., Gat, O., Inbar, Y., Velan, B., Cohen, S. & Shafferman, A. (2002) Search for potential vaccine candidate ORFs in the B. anthracis virulence plasmid pXO1-in silico and in vitro screening. Infect Immun, 70(12), 6817–27.
Ariel, N., Zvi, A., Makarova, K., Chitlaru, T., Elhanay, E., Velan, B., Cohen, S., Friedlander, A. & Shafferman, A. (2003) Genome-based bioinformatic selection of chromosomal B. anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun, 71(8), 4563–79.
Aronson, A. I., Bell, C. & Fulroth, B. (2005) Plasmid-encoded regulator of extracellular proteases in Bacillus anthracis. J Bacteriol, 187(9), 3133–38.
Bradley, K., Mogridge, J., Mourez, M., Collier, B. & Young, J. (2001) Identification of the cellular receptor for anthrax toxin. Nature, 414(6860), 225–29.
Brossier, F., Levy, M. & Mock, M. (2002) Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun 70(2), 661–64.
Cendrowsky, S., Macarthur, W. & Hanna, P. (2004) Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Mol Microbiol 51(2), 407–17.
Chitlaru, T., Ariel, N., Zvi, A., Lion, M., Velan, B., Shafferman, A. & Elhanany, E. (2004) Identification of chromosomally encoded membranal polypeptides of Bacillus anthracis by a proteomic analysis: prevalence of proteins containing S-layer homology domains. Proteomics, 4(3), 677–91.
Chitlaru, T., Gat, O., Gozlan, Y., Ariel, N. & Shafferman, A. (2006) Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross-talk mechanisms modulate extracellular proteolytic activities. J Bacteriol 188(10), 3551–71.
Chitlaru, T., Gat. O., Gozlan, Y., Grosfeld, H., Inbar, I. & Shafferman, A. (2007) Identification of in vivo expressed immunogenic proteins by serological proteome analysis of Bacillus anthracis secretome. Infect Immun 75(6), 2841–52.
Chitlaru, T. & Shafferman, A. (2009) Proteomic studies of Bacillus anthracis. Future Microbiol, 4(8), 983–98.
Collier, R. J. (2009) Membrane translocation by anthrax toxin. Mol Aspects Med, 30, 413–22.
Fellows, P. F., Linscott, M. K., Ivins, B. E., Pitt, M. L. M., Rossi, Gibbs, P. H. & Friedlander, A. M. (2001) Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine, 19(23–24), 3241–7.
Fisher, N., Sheraton-Rama, L., Herring-Palmer, A., Heffernan, B., Bergman, N. & Hanna, P. (2006) The dltABCD operon of Bacillus anthracis Sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J Bacteriol, 188(4), 1301–9.
Fouet, A. & Mock, M. (2006) Regulatory networks for virulence and persistence of Bacillus anthracis. Curr Opin Microbiol 9(2), 160–6.
Fouet, A. (2009) The surface of Bacillus anthracis. Mol Aspect Med, 30, 374–85.
Friedlander, A., Welkos, S. & Ivins, B. (2002) Anthrax Vaccines. Curr Top Microbiol Immun, 271, 34–60.
Gat, O., Grosfeld, H., Ariel, N., Inbar, I., Zaide, G., Broder, Y., Zvi, A., Chitlaru, T., Altboum, Z., Stein, D., Cohen, S. & Shafferman, A. (2006) Search for Bacillus anthracis Potential Vaccine Candidates by a Functional Genomic-Serologic screen. Infect Immun, 74(7), 3987–4001.
Gat, O., Grosfeld, H. & Shafferman, A. (2007) In vitro screen of bioinformatically selected Bacillus anthracis vaccine candidates by coupled transcription, translation and immunoprecipitation analysis. In vitro transcription and translation protocols. In: Grandi, G. (ed), Methods in molecular biology, Humana, Totowa, NJ, 375, pp. 211–33.
Gat, O., Mendelson, I., Chitlaru, T., Ariel, N., Altboum, Z., Levy, H., Weiss, S., Grosfeld, H., Cohen, S. & Shafferman, A. (2005) The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol Microbiol, 58(2), 533–51.
Gat, O., Zaide, G., Inbar, I., Grosfeld, H., Chitlaru, T., Levy, H. & Shafferman, A. (2008) Characterization of Bacillus anthracis iron-regulated surface determinant (Isd) proteins containing NEAT domains. Mol Microbiol 70(4), 983–99.
Gohar M., Faegri, K., Perchat, S., Ravnum, S., Okstad, O. A., Gominet, M., Kolsto, A. B. & Lereclus, D. (2008) The PlcR virulence regulon of Bacillus cereus. PLoS One 3(7), e2793, doi. 10.1371.
Lacy, T. M., & Collier, R. J. (2002) Structure and Function of Anthrax toxin. Curr Top Microbiol Immun, 271, 62–85.
Leppla, S. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Nat Acad Sci USA, 79(10), 3162–6.
Leppla, S. H. (1995) Anthrax toxins. In Moss, J., Iglewski, B., Vaughan, M. & Tu, A. T. (ed.), Bacterial toxins and virulence factors in disease. Marcel Dekker, New York, NY, pp. 543–72.
Klimpel, K. R., Arora, N. & Leppla, S. H. (1994) Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol, 13(6), 1093–100.
Koehler, T. M. (2009) Bacillus anthracis physiology and genetics. Molecular Aspects of Medicine 30(6), 386–396.
Mesnage, S., Tosi-Couture, E., Mock, M., Gounon, P. & Fouet, A. (1997) Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol Microbiol 23(6), 1147–55.
Mignot, T., Mock, M., Robichon, D., Landier, A., Lereclus, D. & Fouet, A. (2001). The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol Microbiol, 42(5), 1189–98.
Mignot, T., Mock, M. & Fouet, A. (2003) A plasmid-encoded regulator couples the synthesis of toxins and surface structures in Bacillus anthracis. Mol Microbiol, 47(4), 917–27.
Mock, M. & Fouet, A. (2001) Anthrax. Ann Rev Microbiol 55, 647-71.
Perchat, S., Gominet, M., Ramarao, N., Nielsen-Leroux, C., Gohar, M. & Lereclus, D. (2007) Characterization of a new quorum-sensing system in the Bacillus cereus group. Bacillus-ACT 2007, International Conference on B. anthracis, B. cereus and B. thuringiensis, Oslo, Norway.
Perego, M. & HOCH, J. A. (2008) Commingling regulatory systems following acquisition of virulence plasmids by Bacillus anthracis. Trends Microbiol, 16(5), 215–21.
Sela-Abramovich, S., Chitlaru, T., Gat, O., Grosfeld, H., Cohen, O. & Shafferman, A. (2009) Novel and Unique Diagnostic Biomarkers for Bacillus anthracis Infection. Appl Environl Microbiol , 75(19), 6157–67.
Wilson, A. C., Soyer, M., Hoch, J. A. & Perego, M. (2008) The bicarbonate transporter is essential for Bacillus anthracis lethality. PLoS Pathogens 4(11), e1000210.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Chitlaru, T. et al. (2010). Proteomic Studies of Bacillus anthracis Reveal In Vitro CO2-Modulation and Expression During Infection of Extracellular Proteases. In: Shafferman, A., Ordentlich, A., Velan, B. (eds) The Challenge of Highly Pathogenic Microorganisms. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9054-6_2
Download citation
DOI: https://doi.org/10.1007/978-90-481-9054-6_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9053-9
Online ISBN: 978-90-481-9054-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)